Specifically, we found that low expression levels of C3AR1 are associated with resistance to chemotherapy in colorectal and breast cancer but increased the drug sensitivity in GBM and ovarian cancer cohorts. The gene discussed is C3AR1; the disease is ovarian carcinoma.